FLT3 and acute myeloid leukemia: Additionally, we observed that MDS + AML (Fig. S7a, p = 1.8e-04) and AML patients (Fig. S7b, p = 1.2e-04) with the FLT3 mutation showed a poor prognosis, compared to the FLT3 wild-type group.